TipRanks
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market
Want to see DRMA full AI Analyst Report?

Dermata Therapeutics (DRMA) Ownership - Who Owns Dermata Therapeutics?

161 Followers

Dermata Therapeutics (DRMA) Ownership Overview

20.63%0.41%<0.01%0.11%78.86%
20.63% Insiders
<0.01% Other Institutional Investors
0.11% ETFs
78.86% Public Companies and
Individual Investors
The ownership structure of Dermata Therapeutics (DRMA) stock is a mix of institutional, retail, and individual investors. Approximately 0.52% of the company’s stock is owned by Institutional Investors, 20.63% is owned by Insiders, and 78.86% is owned by Public Companies and Individual Investors.
The ownership structure of Dermata Therapeutics (DRMA) stock is a mix of institutional, retail, and individual investors. Approximately 0.41% of the company’s stock is owned by Institutional Investors, 20.63% is owned by Insiders, and 0.11% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 16, 2026
xxxxxxxxxxxxx
$13
Mar 17, 2026
xxxxxxxxxxxxx
$1270

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
372,615Insider7.52%325,666
232,463Insider4.69%203,173
196,946Insider3.97%172,131
81,469Insider1.64%71,204
62,398Insider1.26%54,536
27,560Insider0.56%24,087
24,184Insider0.49%21,137
23,443Insider0.47%20,489
20,101Institution0.41%17,568
5,438Institution0.11%4,753

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
20,101Institution0.41%17,568

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
5,438Institution0.11%5,982

FAQ

Who Owns Dermata Therapeutics (DRMA)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 20.63% is held by insiders, and 78.86% is held by retail investors.
    What percentage of Dermata Therapeutics (DRMA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately <0.01% of Dermata Therapeutics (DRMA) stock is held by institutional investors.
      What percentage of Dermata Therapeutics (DRMA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 78.86% of Dermata Therapeutics (DRMA) stock is held by retail investors.
        Who owns the most shares of Dermata Therapeutics (DRMA)?
        Gerald Proehl owns the most shares of Dermata Therapeutics (DRMA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.